Skip to content
Boustead
Boustead
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Release
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Release
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us

Daily Archives: August 10, 2011

You are here:
  1. Home
  2. 2011
  3. August
  4. 10

Acquires Idaman Pharma Manufacturing Sdn Bhd

Media ReleasesBy aiman.jasmin@shareinvestor.comAugust 10, 2011

KUALA LUMPUR, August 10, 2011 – Pharmaniaga Berhad (Pharmaniaga) recorded a profit after tax of RM14.1 million for its second quarter ended 30 June 2011. For the cumulative period, the Group delivered an improved profit after tax of RM29.6 million, an increase of 24% compared with RM23.9 million recorded in the same period last year.…

Go to Top
Boustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Release
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us